Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 crossover study of glycopyrrolate added to Foster in uncontrolled asthma
2013-003043-36Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glycopyrronium and beclometasone dipropionate + formoterol in asthma (4 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: FEV1 AUC0-12h normalized by time on Day 42. Started Dec 2013; status: completed.
02
Drugs
glycopyrroniumbeclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2013-003043-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003043-36.